Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence summary HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS FPKM FPKM max in non-specific AICDA AID, ARP2, CDA2, HIGM2 ENSG00000111732 Activation-induced cytidine deaminase 12 8602166-8612871 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 13 appendix: 2.8;lymph node: 13.1;tonsil: 11.2 spleen: 0.6 BANK1 BANK, FLJ20706 ENSG00000153064 B-cell scaffold protein with ankyrin repeats 1 4 101411286-102074812 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037002 Supportive Group enriched 5 appendix: 33.8;lymph node: 74.7;spleen: 48.2;tonsil: 84.6 urinary bladder: 11.3 BLK MGC10442 ENSG00000136573 BLK proto-oncogene, Src family tyrosine kinase 8 11494001-11564604 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005093 Uncertain Group enriched 9 appendix: 13.1;lymph node: 41.4;spleen: 24.3;tonsil: 45.8 urinary bladder: 3.5 BTLA BTLA1, CD272 ENSG00000186265 B and T lymphocyte associated 3 112463968-112499561 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047211, HPA062029 Supportive Group enriched 6 appendix: 8.9;lymph node: 21.5;spleen: 8.8;tonsil: 23.3 stomach: 2.5 CASP5 ICE(rel)III ENSG00000137757 Caspase 5, apoptosis-related cysteine peptidase 11 104994235-105023168 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA040937 Uncertain Group enriched 6 appendix: 12.6;colon: 10.5;duodenum: 6.3;rectum: 9.6;small intestine: 11.7 smooth muscle: 1.5 CCL19 CKb11, ELC, exodus-3, MIP-3b, SCYA19 ENSG00000172724 Chemokine (C-C motif) ligand 19 9 34689567-34691277 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 5 appendix: 524.4;lymph node: 506.2;tonsil: 469.2 adipose tissue: 99.3 CCL7 FIC, MARC, MCP-3, MCP3, NC28, SCYA6, SCYA7 ENSG00000108688 Chemokine (C-C motif) ligand 7 17 34270221-34272242 Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 9 appendix: 2.7;bone marrow: 11.4 rectum: 0.7 CCR7 BLR2, CD197, CDw197, CMKBR7, EBI1 ENSG00000126353 Chemokine (C-C motif) receptor 7 17 40553769-40565472 Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003796 Supportive Group enriched 5 appendix: 57.6;lymph node: 68.9;spleen: 23.6;tonsil: 67.3 urinary bladder: 9.9 CCR9 CDw199, GPR-9-6, GPR28 ENSG00000173585 Chemokine (C-C motif) receptor 9 3 45886504-45903177 CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB006839 Uncertain Group enriched 6 appendix: 1.0;duodenum: 2.9;small intestine: 4.1;spleen: 0.9 tonsil: 0.4 CD19 ENSG00000177455 CD19 molecule 16 28931939-28939346 CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016110 Supportive Group enriched 9 appendix: 24.3;lymph node: 61.4;spleen: 33.9;tonsil: 64.3 urinary bladder: 4.9 CD72 CD72b, LYB2 ENSG00000137101 CD72 molecule 9 35609533-35646810 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002505, HPA044658 Supportive Group enriched 7 appendix: 16.9;lymph node: 52.3;spleen: 42.6;tonsil: 35.7 urinary bladder: 5.5 CEACAM4 CGM7 ENSG00000105352 Carcinoembryonic antigen-related cell adhesion molecule 4 19 41618971-41627074 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA012801 Uncertain Group enriched 7 appendix: 6.1;bone marrow: 14.9;spleen: 9.6 adipose tissue: 1.4 CHRDL2 BNF1 ENSG00000054938 Chordin-like 2 11 74696429-74731385 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021771 Uncertain Uncertain Mitochondria Group enriched 13 appendix: 92.2;endometrium: 64.1;gallbladder: 100.1;smooth muscle: 91.5;urinary bladder: 33.5 placenta: 5.9 CLEC17A FLJ45910 ENSG00000187912 C-type lectin domain family 17, member A 19 14583084-14611157 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 9 appendix: 9.7;lymph node: 17.5;spleen: 11.2;tonsil: 21.2 urinary bladder: 1.5 CLEC4D CLECSF8, Mpcl ENSG00000166527 C-type lectin domain family 4, member D 12 8509475-8522366 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004906 Uncertain Group enriched 7 appendix: 5.8;bone marrow: 22.7 spleen: 2.0 CLEC5A CLECSF5, MDL-1 ENSG00000258227 C-type lectin domain family 5, member A 7 141927357-141947007 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 6 appendix: 6.1;bone marrow: 21.4 lung: 2.2 CNR2 CB2 ENSG00000188822 Cannabinoid receptor 2 (macrophage) 1 23870526-23913362 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB009719 Uncertain Group enriched 8 appendix: 2.1;lymph node: 6.6;spleen: 5.7;tonsil: 6.8 bone marrow: 0.7 CR2 CD21 ENSG00000117322 Complement component (3d/Epstein Barr virus) receptor 2 1 207454230-207489895 CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002659, HPA052942, HPA060715 Supportive Group enriched 15 appendix: 47.0;lymph node: 145.4;spleen: 62.0;tonsil: 141.4 stomach: 6.7 CXCL13 ANGIE, ANGIE2, BCA-1, BLC, BLR1L, SCYB13 ENSG00000156234 Chemokine (C-X-C motif) ligand 13 4 77511753-77611834 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA052613 Uncertain Group enriched 6 appendix: 122.2;lymph node: 456.9;spleen: 280.9;tonsil: 365.6 urinary bladder: 49.9 CXCL9 CMK, crg-10, Humig, MIG, SCYB9 ENSG00000138755 Chemokine (C-X-C motif) ligand 9 4 76001275-76007488 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 6 appendix: 62.3;lymph node: 269.3 tonsil: 26.3 CXCR5 BLR1, CD185, MDR15 ENSG00000160683 Chemokine (C-X-C motif) receptor 5 11 118883766-118897799 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB026149, HPA042432 Supportive Group enriched 5 appendix: 8.9;bone marrow: 5.2;lymph node: 23.2;spleen: 14.9;tonsil: 14.1 urinary bladder: 2.6 DRD5 DRD1B, DRD1L2 ENSG00000169676 Dopamine receptor D5 4 9781680-9784009 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA048930 Supportive Group enriched 8 appendix: 1.1;cerebral cortex: 0.9 prostate: 0.1 FAM129C BCNP1, FLJ39802 ENSG00000167483 Family with sequence similarity 129, member C 19 17523301-17553839 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043277 Uncertain Group enriched 16 appendix: 7.7;bone marrow: 7.6;lymph node: 16.7;spleen: 23.9;tonsil: 7.7 stomach: 0.8 FCER2 CD23, CD23A, CLEC4J, FCE2 ENSG00000104921 Fc fragment of IgE, low affinity II, receptor for (CD23) 19 7688758-7702146 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002624, HPA008928 Supportive Uncertain Nucleus but not nucleoli Group enriched 9 appendix: 14.8;lymph node: 33.6;spleen: 37.4;tonsil: 35.5 adipose tissue: 3.2 FCN1 FCNM ENSG00000085265 Ficolin (collagen/fibrinogen domain containing) 1 9 134905890-134917963 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000685, HPA001295, CAB016760 Supportive Group enriched 6 appendix: 188.2;bone marrow: 481.8 spleen: 58.6 FCRL2 CD307b, FCRH2, IRTA4, SPAP1 ENSG00000132704 Fc receptor-like 2 1 157745733-157777132 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB017619, HPA041426 Uncertain Group enriched 8 appendix: 9.9;lymph node: 19.0;spleen: 15.1;tonsil: 19.7 urinary bladder: 2.0 FCRL3 CD307c, FCRH3, IFGP3, IRTA3, SPAP2, SPAP2a, SPAP2b, SPAP2c, SPAP2d, SPAP2e ENSG00000160856 Fc receptor-like 3 1 157674321-157700857 CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA015508 Uncertain Group enriched 11 appendix: 12.8;lymph node: 41.7;spleen: 22.8;tonsil: 29.5 urinary bladder: 2.3 FCRL4 CD307d, FCRH4, IGFP2, IRTA1 ENSG00000163518 Fc receptor-like 4 1 157573749-157598080 Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA054030 Uncertain Group enriched 9 appendix: 2.7;lymph node: 3.3;tonsil: 8.9 spleen: 0.5 FCRLA FCRL, FCRLa, FCRLb, FCRLc1, FCRLc2, FCRLd, FCRLe, FCRLM1, FCRLX, FREB, MGC4595 ENSG00000132185 Fc receptor-like A 1 161706972-161714352 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016545 Supportive Group enriched 10 appendix: 22.3;lymph node: 60.8;spleen: 38.7;tonsil: 84.6 urinary bladder: 5.2 FUT7 ENSG00000180549 Fucosyltransferase 7 (alpha (1,3) fucosyltransferase) 9 137030174-137033010 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 5 appendix: 0.7;bone marrow: 1.4;lymph node: 2.2;spleen: 1.7;tonsil: 1.5 urinary bladder: 0.2 GPR97 Pb99, PGR26 ENSG00000182885 G protein-coupled receptor 97 16 57668187-57689378 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040469 Uncertain Group enriched 6 appendix: 10.4;bone marrow: 49.8 adipose tissue: 4.6 HLA-DOB ENSG00000241106 Major histocompatibility complex, class II, DO beta 6 32812763-32817048 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013846 Uncertain Group enriched 6 appendix: 19.5;lymph node: 44.6;spleen: 26.5;tonsil: 82.7 urinary bladder: 6.6 HTR3A 5-HT3A, 5-HT3R, HTR3 ENSG00000166736 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic 11 113974881-113990313 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 6 appendix: 1.8;lymph node: 5.4;tonsil: 6.6 small intestine: 0.8 IL17A CTLA8, IL-17, IL-17A, IL17 ENSG00000112115 Interleukin 17A 6 52186387-52190638 Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA052258 Uncertain Group enriched 5 appendix: 0.7;tonsil: 1.1;urinary bladder: 1.2 gallbladder: 0.2 IL24 C49A, FISP, IL-24, IL10B, mda-7, Mob-5, ST16 ENSG00000162892 Interleukin 24 1 206897443-206904139 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA008252, CAB025972 Uncertain Uncertain Nucleus but not nucleoli, Cytoplasm Group enriched 7 appendix: 9.5;lymph node: 19.2;spleen: 14.5;tonsil: 17.3 urinary bladder: 2.2 IL26 AK155, IL-26 ENSG00000111536 Interleukin 26 12 68201351-68225821 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 5 appendix: 0.8;tonsil: 0.8;urinary bladder: 1.2 lymph node: 0.1 L1TD1 ECAT11, FLJ10884 ENSG00000240563 LINE-1 type transposase domain containing 1 1 62194831-62212328 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA028501, HPA030064 Uncertain Group enriched 5 appendix: 4.5;colon: 3.5;placenta: 8.8;testis: 6.2 rectum: 1.0 LTB p33, TNFC, TNFSF3 ENSG00000227507 Lymphotoxin beta (TNF superfamily, member 3) 6 31580525-31582522 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA048884 Uncertain Uncertain Centrosome, Nucleus, Nucleoli Group enriched 6 appendix: 78.5;lymph node: 103.5;spleen: 137.7;tonsil: 64.4 stomach: 16.3 MAB21L2 ENSG00000181541 Mab-21-like 2 (C. elegans) 4 150581922-150584693 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 8 adrenal gland: 3.1;appendix: 7.3;colon: 11.0;duodenum: 6.5;rectum: 7.8;small intestine: 8.5;smooth muscle: 15.1 esophagus: 1.0 MCEMP1 C19orf59, MGC132456 ENSG00000183019 Mast cell-expressed membrane protein 1 19 7676628-7679826 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014731 Supportive Group enriched 10 appendix: 16.5;bone marrow: 33.0;lung: 53.2 smooth muscle: 3.5 MEF2B RSRFR2 ENSG00000213999 Myocyte enhancer factor 2B 19 19145568-19170289 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004734 Supportive Group enriched 11 appendix: 8.1;lymph node: 22.8;tonsil: 20.2 urinary bladder: 1.5 MMP3 STMY, STMY1 ENSG00000149968 Matrix metallopeptidase 3 (stromelysin 1, progelatinase) 11 102835801-102843803 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007875 Uncertain Group enriched 7 appendix: 16.7;endometrium: 31.1;urinary bladder: 7.9 stomach: 2.4 MS4A1 B1, Bp35, CD20, MS4A2 ENSG00000156738 Membrane-spanning 4-domains, subfamily A, member 1 11 60455752-60470760 CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000015, HPA014341, HPA014391 Supportive Group enriched 13 appendix: 176.9;lymph node: 562.2;spleen: 290.3;tonsil: 731.0 urinary bladder: 33.2 MUC4 ENSG00000145113 Mucin 4, cell surface associated 3 195746765-195812277 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005895, CAB013536 Uncertain Group enriched 9 appendix: 2.4;colon: 7.6;esophagus: 2.9;rectum: 6.0;stomach: 2.3;tonsil: 3.1;urinary bladder: 2.2 fallopian tube: 0.4 NOS2 HEP-NOS, iNOS, NOS, NOS2A ENSG00000007171 Nitric oxide synthase 2, inducible 17 27756766-27800499 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB002014 Uncertain Group enriched 6 appendix: 12.3;colon: 3.2;duodenum: 8.4;rectum: 7.1;small intestine: 15.5;urinary bladder: 5.2 smooth muscle: 1.3 P2RX5 P2X5 ENSG00000083454 Purinergic receptor P2X, ligand-gated ion channel, 5 17 3672199-3696404 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA021948, HPA067827 Supportive Supportive Cytoplasm Group enriched 9 appendix: 26.2;lymph node: 58.5;spleen: 48.8;tonsil: 37.4 bone marrow: 4.8 POU2F2 OCT2, OTF2 ENSG00000028277 POU class 2 homeobox 2 19 42086110-42196585 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002513, HPA064404 Supportive Group enriched 5 appendix: 19.7;lymph node: 36.1;spleen: 22.4;tonsil: 29.4;urinary bladder: 9.1 testis: 4.6 SP140 LYSP100-A, LYSP100-B ENSG00000079263 SP140 nuclear body protein 2 230203110-230313215 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006162, HPA067493 Supportive Uncertain Nucleoli, Mitochondria Group enriched 5 appendix: 19.4;lymph node: 38.7;spleen: 20.5;tonsil: 39.2 urinary bladder: 5.7 TLR10 CD290 ENSG00000174123 Toll-like receptor 10 4 38772239-38782990 CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 appendix: 16.1;lymph node: 39.1;spleen: 20.5;tonsil: 42.3 urinary bladder: 4.7 TMC8 EVER2, EVIN2 ENSG00000167895 Transmembrane channel-like 8 17 78130770-78142968 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA054429 Uncertain Group enriched 5 appendix: 40.2;bone marrow: 43.3;lymph node: 69.2;spleen: 63.2;tonsil: 37.1 lung: 9.7 TMEM156 FLJ23235 ENSG00000121895 Transmembrane protein 156 4 38966744-39032922 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA029348 Uncertain Group enriched 5 appendix: 7.9;lymph node: 19.6;spleen: 9.3;tonsil: 22.0;urinary bladder: 4.7 stomach: 2.3 TNFRSF13C BAFFR, CD268 ENSG00000159958 Tumor necrosis factor receptor superfamily, member 13C 22 41925041-41926818 CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA003246, CAB008380 Supportive Uncertain Nucleus Group enriched 8 appendix: 13.6;lymph node: 25.8;spleen: 27.1;tonsil: 24.0 bone marrow: 2.8 VIP ENSG00000146469 Vasoactive intestinal peptide 6 152750798-152759765 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017324, CAB018649 Supportive Group enriched 5 appendix: 147.1;colon: 61.1;rectum: 52.4;small intestine: 37.5;smooth muscle: 33.3 duodenum: 13.2